{"log_id": 2448616567288939530, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 8e-06, "average": 0.998571, "min": 0.988583}, "location": {"width": 807, "top": 186, "height": 29, "left": 256}, "words": "当从静脉给药转换成口服给药时无需调整剂量。对起始治疗时应用利奈唑胺注射液的患"}, {"probability": {"variance": 8.2e-05, "average": 0.997414, "min": 0.949477}, "location": {"width": 633, "top": 222, "height": 27, "left": 211}, "words": "者,医生可根据临床状况,予以利奈唑胺片剂或口服混悬液继续治疗"}, {"probability": {"variance": 0.000269, "average": 0.98965, "min": 0.961266}, "location": {"width": 89, "top": 290, "height": 26, "left": 210}, "words": "静脉给药"}, {"probability": {"variance": 0.000144, "average": 0.996658, "min": 0.924733}, "location": {"width": 811, "top": 323, "height": 28, "left": 254}, "words": "利奈唑胺静脉注射剂为单次使用的即用型输液袋。静脉给药时,应在使用前目测微粒物"}, {"probability": {"variance": 4e-06, "average": 0.998996, "min": 0.991835}, "location": {"width": 856, "top": 357, "height": 26, "left": 208}, "words": "质。用力挤压输液袋以检查细微的渗漏。鉴于无菌状况可能受损害,若发现有渗漏应丢弃溶"}, {"probability": {"variance": 0, "average": 0.999955, "min": 0.999955}, "location": {"width": 26, "top": 392, "height": 26, "left": 207}, "words": "液"}, {"probability": {"variance": 0.000284, "average": 0.996149, "min": 0.892356}, "location": {"width": 815, "top": 422, "height": 28, "left": 251}, "words": "利奈唑胺静脉注射剂应在30至120分钟内静脉输注完毕。不能将此静脉输液袋串联在其"}, {"probability": {"variance": 1.4e-05, "average": 0.998109, "min": 0.981399}, "location": {"width": 855, "top": 456, "height": 27, "left": 208}, "words": "它静脉给药通路中。不可在此溶液中加入其它药物。如果利奈唑胺静脉注射需与其它药物合"}, {"probability": {"variance": 1.7e-05, "average": 0.998409, "min": 0.975862}, "location": {"width": 859, "top": 490, "height": 29, "left": 206}, "words": "并应用,应根据每种药物的推荐剂量和给药途径分别应用。尤其应注意,利奈唑胺静脉注射"}, {"probability": {"variance": 1.2e-05, "average": 0.998795, "min": 0.980445}, "location": {"width": 858, "top": 522, "height": 28, "left": 207}, "words": "剂与下列药物通过Y型接口联合给药时,可导致物理性质不配伍。这些药物包括:二性霉素"}, {"probability": {"variance": 0.000305, "average": 0.996409, "min": 0.886188}, "location": {"width": 860, "top": 554, "height": 28, "left": 204}, "words": "B、盐酸氯丙嗪、安定、喷他脒异硫代硫酸盐、红霉素乳糖酸脂、苯妥英钠和甲氯苄啶一磺胺"}, {"probability": {"variance": 2e-06, "average": 0.998834, "min": 0.994001}, "location": {"width": 811, "top": 589, "height": 27, "left": 206}, "words": "甲基异唑。此外,利奈唑胺静脉注射液与头孢曲松钠合用可致二者的化学性质不配伍"}, {"probability": {"variance": 4e-06, "average": 0.999008, "min": 0.991124}, "location": {"width": 817, "top": 622, "height": 26, "left": 248}, "words": "如果同一静脉通路用于几个药物依次给药,在应用利奈唑胺静脉注射液前及使用后,应"}, {"probability": {"variance": 2.9e-05, "average": 0.998516, "min": 0.967407}, "location": {"width": 794, "top": 654, "height": 26, "left": 205}, "words": "使用与利奈唑胺静脉注射剂和其它药物可配伍的溶液进行冲洗(见可配伍静脉注射液"}, {"probability": {"variance": 1e-06, "average": 0.99904, "min": 0.996843}, "location": {"width": 196, "top": 688, "height": 26, "left": 248}, "words": "可配伍的静脉注射液"}, {"probability": {"variance": 0.0001, "average": 0.995946, "min": 0.963199}, "location": {"width": 224, "top": 720, "height": 26, "left": 247}, "words": "5%葡萄糖注射液,USP"}, {"probability": {"variance": 0.000424, "average": 0.986294, "min": 0.931361}, "location": {"width": 239, "top": 753, "height": 25, "left": 245}, "words": "0.9%氯化钠注射液,USP"}, {"probability": {"variance": 0.000225, "average": 0.990894, "min": 0.951004}, "location": {"width": 193, "top": 787, "height": 26, "left": 242}, "words": "乳酸林格氏液,USP"}, {"probability": {"variance": 8e-06, "average": 0.998845, "min": 0.986213}, "location": {"width": 820, "top": 818, "height": 26, "left": 245}, "words": "在使用时方可拆除输液袋的外包装袋。在室温下贮藏,避免冷冻。利奈唑胺静脉注射液"}, {"probability": {"variance": 3e-06, "average": 0.999045, "min": 0.993032}, "location": {"width": 590, "top": 850, "height": 26, "left": 201}, "words": "可呈黄色,且随着时间延长可加深,但对药物含量没有不良影响"}, {"probability": {"variance": 2e-06, "average": 0.999206, "min": 0.995924}, "location": {"width": 116, "top": 915, "height": 25, "left": 212}, "words": "【不良反应】"}, {"probability": {"variance": 4e-06, "average": 0.999059, "min": 0.990544}, "location": {"width": 821, "top": 947, "height": 27, "left": 244}, "words": "因为开展临床试验的条件各不相同,在某种药物的临床试验中观察到的不良反应率不能"}, {"probability": {"variance": 0, "average": 0.999712, "min": 0.997856}, "location": {"width": 865, "top": 978, "height": 27, "left": 201}, "words": "与另一种药物在临床试验中的不良反应率直接比较,并且可能无法反映在临床实践中观察到"}, {"probability": {"variance": 0, "average": 0.999424, "min": 0.998109}, "location": {"width": 131, "top": 1013, "height": 24, "left": 199}, "words": "的不良反应率"}, {"probability": {"variance": 1e-06, "average": 0.998741, "min": 0.997342}, "location": {"width": 88, "top": 1078, "height": 25, "left": 198}, "words": "成年患者"}, {"probability": {"variance": 0.005832, "average": 0.986599, "min": 0.509957}, "location": {"width": 830, "top": 1107, "height": 29, "left": 239}, "words": "在疗程最长达28天的7个Ⅲ期阳性药物对照临床研究中,入选了2046例患者以评价利"}, {"probability": {"variance": 9e-06, "average": 0.996919, "min": 0.989956}, "location": {"width": 152, "top": 1142, "height": 26, "left": 196}, "words": "奈唑胺的安全性"}, {"probability": {"variance": 0.007343, "average": 0.980861, "min": 0.424513}, "location": {"width": 829, "top": 1174, "height": 26, "left": 239}, "words": "在治疗非复杂性皮肤和皮肤软组织感染(uSS)的患者中,25.4%的使用利奈唑胺的患者和"}, {"probability": {"variance": 0.000153, "average": 0.996657, "min": 0.930464}, "location": {"width": 845, "top": 1206, "height": 27, "left": 199}, "words": "9.6%的使用对照药物的患者至少出现一起与药物相关的不良事件。对于所有其它适应症"}, {"probability": {"variance": 9.9e-05, "average": 0.996875, "min": 0.937359}, "location": {"width": 867, "top": 1240, "height": 25, "left": 198}, "words": "2.4%的使用利奈唑胺的患者和14.3%的使用对照药物的患者至少出现一起与药物相关的不良"}, {"probability": {"variance": 7e-06, "average": 0.997276, "min": 0.994668}, "location": {"width": 44, "top": 1274, "height": 22, "left": 193}, "words": "事件"}, {"probability": {"variance": 1e-06, "average": 0.999342, "min": 0.994227}, "location": {"width": 815, "top": 1305, "height": 26, "left": 252}, "words": "在这些研究中,按不良事件的严重程度统计,85%的利奈唑胺不良事件为轻至中度。表"}, {"probability": {"variance": 3e-06, "average": 0.999221, "min": 0.992121}, "location": {"width": 879, "top": 1337, "height": 27, "left": 189}, "words": "2为发生率超过2%的不良事件。利奈唑胺最常见的不良事件为腹泻(不同研究中发生率为"}, {"probability": {"variance": 0.000852, "average": 0.993607, "min": 0.79121}, "location": {"width": 858, "top": 1370, "height": 26, "left": 208}, "words": "8%至11.0%),头痛(不同研究中发生率为0.5%至11.3%)和恶心(不同研究中发生率为3.4%"}, {"probability": {"variance": 0.003092, "average": 0.971984, "min": 0.860778}, "location": {"width": 75, "top": 1407, "height": 22, "left": 193}, "words": "至9.6%"}, {"probability": {"variance": 3.7e-05, "average": 0.996785, "min": 0.974608}, "location": {"width": 771, "top": 1436, "height": 29, "left": 242}, "words": "表2利奈唑胺阳性药物对照的临床研究中,成年患者中发生率≥2%的不良事件"}, {"probability": {"variance": 5e-05, "average": 0.99277, "min": 0.985689}, "location": {"width": 67, "top": 1476, "height": 23, "left": 278}, "words": "事件"}, {"probability": {"variance": 7.9e-05, "average": 0.990415, "min": 0.975223}, "location": {"width": 76, "top": 1477, "height": 21, "left": 552}, "words": "利奈唑胺"}, {"probability": {"variance": 0, "average": 0.999343, "min": 0.998648}, "location": {"width": 99, "top": 1476, "height": 22, "left": 853}, "words": "所有对照药"}, {"probability": {"variance": 0, "average": 0.999961, "min": 0.999929}, "location": {"width": 41, "top": 1547, "height": 21, "left": 290}, "words": "腹泻"}, {"probability": {"variance": 0, "average": 0.999678, "min": 0.999391}, "location": {"width": 40, "top": 1580, "height": 22, "left": 289}, "words": "头痛"}, {"probability": {"variance": 1e-05, "average": 0.997269, "min": 0.990155}, "location": {"width": 146, "top": 1627, "height": 22, "left": 552}, "words": "第3页,共29页"}, {"probability": {"variance": 0.011373, "average": 0.924159, "min": 0.749003}, "location": {"width": 116, "top": 1653, "height": 21, "left": 566}, "words": "辉瑞——机密"}], "language": 3}